Effect of paroxetine hydrochloride (Paxil®) on fatigue and depression in breast cancer patients receiving chemotherapy.

Autor: Joseph A. Roscoe, Gary R. Morrow, Jane T. Hickok, Karen M. Mustian, Jennifer J. Griggs, Sara E. Matteson, Peter Bushunow, Raman Qazi, Brian Smith
Zdroj: Breast Cancer Research & Treatment; Feb2005, Vol. 89 Issue 3, p243-249, 7p
Abstrakt: Summary Background. Fatigue can significantly interfere with a cancer patient’s ability to fulfill daily responsibilities and enjoy life. It commonly co-exists with depression in patients undergoing chemotherapy, suggesting that administration of an antidepressant that alleviates symptoms of depression could also reduce fatigue. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index